| Literature DB >> 32686118 |
Adrian B Levine1, Jason Peng1,2, David Farnell1, Mitchell Nursey1,2, Yiping Wang1,2, Julia R Naso1, Hezhen Ren1, Hossein Farahani1,2, Colin Chen1,2, Derek Chiu1, Aline Talhouk3, Brandon Sheffield4, Maziar Riazy1, Philip P Ip5, Carlos Parra-Herran6, Anne Mills7, Naveena Singh8, Basile Tessier-Cloutier1, Taylor Salisbury1, Jonathan Lee1, Tim Salcudean9, Steven Jm Jones10, David G Huntsman1, C Blake Gilks1, Stephen Yip1, Ali Bashashati1,2,9.
Abstract
Deep learning-based computer vision methods have recently made remarkable breakthroughs in the analysis and classification of cancer pathology images. However, there has been relatively little investigation of the utility of deep neural networks to synthesize medical images. In this study, we evaluated the efficacy of generative adversarial networks to synthesize high-resolution pathology images of 10 histological types of cancer, including five cancer types from The Cancer Genome Atlas and the five major histological subtypes of ovarian carcinoma. The quality of these images was assessed using a comprehensive survey of board-certified pathologists (n = 9) and pathology trainees (n = 6). Our results show that the real and synthetic images are classified by histotype with comparable accuracies and the synthetic images are visually indistinguishable from real images. Furthermore, we trained deep convolutional neural networks to diagnose the different cancer types and determined that the synthetic images perform as well as additional real images when used to supplement a small training set. These findings have important applications in proficiency testing of medical practitioners and quality assurance in clinical laboratories. Furthermore, training of computer-aided diagnostic systems can benefit from synthetic images where labeled datasets are limited (e.g. rare cancers). We have created a publicly available website where clinicians and researchers can attempt questions from the image survey (http://gan.aimlab.ca/).Entities:
Keywords: artificial intelligence; cancer; deep learning; education; pathology; quality assurance
Mesh:
Year: 2020 PMID: 32686118 DOI: 10.1002/path.5509
Source DB: PubMed Journal: J Pathol ISSN: 0022-3417 Impact factor: 7.996